Thrivent Financial for Lutherans’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.74M | Buy |
|
|||||
|
2021
Q1 | $1.44M | Sell |
|
|||||
|
2020
Q4 | $65.8M | Sell |
|
|||||
|
2020
Q3 | $67.4M | Buy |
|
|||||
|
2020
Q2 | $55.1M | Sell |
|
|||||
|
2020
Q1 | $46M | Sell |
|
|||||
|
2019
Q4 | $58.9M | Buy |
|
|||||
|
2019
Q3 | $5.14M | Buy |
|
|||||
|
2019
Q2 | $1.32M | Buy |
|
|||||
|
2019
Q1 | $1.35M | Buy |
|
|||||
|
2018
Q4 | $947K | Buy |
|
|||||
|
2018
Q3 | $1.33M | Buy |
|
|||||
|
2018
Q2 | $1.16M | Sell |
|
|||||
|
2018
Q1 | $104M | Sell |
|
|||||
|
2017
Q4 | $118M | Buy |
|
|||||
|
2017
Q3 | $113M | Sell |
|
|||||
|
2017
Q2 | $104M | Buy |
|
|||||
|
2017
Q1 | $87.3M | Sell |
|
|||||
|
2016
Q4 | $127M | Buy |
|
|||||
|
2016
Q3 | $111M | Buy |
|
|||||
|
2016
Q2 | $73M | Buy |
|
|||||
|
2016
Q1 | $910K | Buy |
|
|||||
|
2015
Q4 | $1.21M | Sell |
|
|||||
|
2015
Q3 | $110M | Sell |
|
|||||
|
2015
Q2 | $141M | Buy |
|
|||||
|
2015
Q1 | $76.5M | Buy |
|
|||||
|
2014
Q4 | $870K | Sell |
|
|||||
|
2014
Q3 | $5.21M | Buy |
|
|||||
|
2014
Q2 | $734K | Buy |
|
|||||
|
2014
Q1 | $700K | Hold |
|
|||||
|
2013
Q4 | $611K | Hold |
|
|||||
|
2013
Q3 | $534K | Sell |
|
|||||
|
2013
Q2 | $627 | Buy |
|